Estrogen and progesterone receptors (ER/PR) were measured in primary tumors and
metastases of 397 breast cancer patients. Survival following mastectomy was significantly …

Estrogen and progestin receptor levels (ER and PgR) in tumors from 506 patients with
primary breast cancer diagnosed in 1979, 1980, and 1981 were measured by a Scatchard …

Abstract From October 1977 to December 1983, estrogen receptor (ER) and progesterone
receptor (PR) levels were measured in 645 tumors from women with primary, unilateral …

The estrogen receptor status in 335 primary breast carcinomas was correlated with disease‐
free interval, survival and site of recurrent disease. Estrogen receptor positive carcinomas …

The value of estrogen receptor (ER) measurements for predicting recurrence and survival
rates in primary breast cancer was examined in 121 women who were followed from 5 to 12 …

To ascertain the role of estrogen (ER) and progesterone (PR) receptors as prognostic
indicators of resectable breast cancer, the records of 204 patients were analyzed whose …

Two‐hundred‐seventeen women with primary breast carcinoma had an estrogen receptor
determination tested by both the dextran‐coated charcoal assay and sucrose density …

The aims of this study were as follows: to confirm that the presence of estrogen (ER) and
progesterone (PgR) receptors is an indicator of clinical behavior of human breast cancer …

The usefulness of estrogen receptor measurements in primary breast tumors in the
prediction of early recurrence was examined in a series of 145 patients. The absence of …

A series of 258 breast cancer patients with known estrogen receptor (ER) status of the
primary tumour who subsequently developed metastases were reviewed for site of first …